Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Vivmark Residential Common Shares of Beneficial Interest (VMRK) Price & Performance

Halozyme Therapeutics Inc. Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Vivmark Residential Common Shares of Beneficial Interest trades at $61.11 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is far larger — about 3.7× Halozyme Therapeutics Inc. Common Stock's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.68% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Vivmark Residential Common Shares of Beneficial Interest for 1 Days on average.